Corneal Collagen Crosslinking with Riboflavin (CXL) is a technique that was first used in 1998 to treat patients with a disease called keratoconus. In keratoconus the cornea (the front clear window of the eye) becomes weak, thin, and irregularly shaped. CXL is now being performed for patients with this condition at nearly 400 centers throughout the world. Through a research study, CXL USA is now able to provide this breakthrough investigational treatment to our patients using this unique advanced technology.
To find a doctor in your area that performs Corneal Cross Linking (CXL) please check out our doctor directory.
© Copyright 2010 Center For Excellence in Eyecare. All Rights Reserved. Medical website by Glacial Multimedia